Frekil
RWE Generation in minutes
Frekil is a company in healthcare based in Bengaluru, KA, India.
Profile
Today, it takes months to understand how drugs perform in the real world, delaying safety insights and leaving patients exposed to unknown risks and benefits for far too long. Frekil turns that months-long process into minutes, with full auditability and scientific rigor.
Frekil accelerates real world evidence (RWE) generation for life sciences companies on their own clinical data from months to minutes. It connects to fragmented clinical data (EHR, Claims, etc.) and lets teams run end-to-end studies from study design, cohort extraction to SAP, statistical analysis, and final reports.
As a business in healthcare, Frekil is listed here with the public details available about it.
Bengaluru, KA, India is where the company is located.
It is recorded at the Spring 2025 stage.
Its team size is recorded as 2 employees.
Directory analysis
Frekil is a Bengaluru-based healthcare startup that accelerates real‑world evidence (RWE) generation for life‑sciences companies, turning a months‑long process into minutes. It connects to fragmented clinical data sources such as EHRs and claims, enabling teams to design studies, extract cohorts, run statistical analyses, and produce final reports all within a single platform.
Positioning: Positioned as a niche RWE solution, Frekil offers rapid, end‑to‑end study execution that could streamline safety and efficacy insights for pharmaceutical and biotech firms. Its focus on auditability and scientific rigor addresses a common bottleneck in clinical data utilization.
Note: Frekil is a Bengaluru startup specializing in rapid real‑world evidence generation for life sciences.
Auto-generated directory analysis from public data · updated 10 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | Bengaluru, KA, India |
| Country | India |
| Employees | 2 |
| Stage | Spring 2025 |
Website: www.frekil.com
Browse related
Create a free account